Ficha del valor · trimestre archivado
ROIV
Roivant Sciences Ltd. · Healthcare · Biotechnology
19Tenedores rastreados
+1Δ titulares
262.46MAcciones mantenidas
$3.97BValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +5.6% ·
flujo de acciones +1.1% ·
nuevas posiciones netas 0.0%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +11 | 408.23M | $14.45B | +15 | −3 |
| Q1 2026 | 122 | +5 | 384.63M | $10.65B | +13 | −9 |
| Q4 2025 | 117 | +1 | 374.22M | $8.12B | +3 | −1 |
| Q3 2025 | 19 | +1 | 262.46M | $3.97B | +1 | −1 |
| Q2 2025 | 16 | +1 | 211.12M | $2.38B | +1 | — |
| Q1 2025 | 12 | +1 | 89.39M | $901.93M | +2 | −1 |
| Q4 2024 | 11 | -2 | 96.86M | $1.15B | — | −2 |
| Q3 2024 | 12 | -1 | 85.45M | $986.08M | +1 | −2 |
| Q2 2024 | 13 | — | 92.40M | $976.70M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 60.77M | +9.5% | $919.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 60.77M | +9.5% | $919.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 60.77M | +9.5% | $919.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 60.77M | +9.5% | $919.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 60.77M | +9.5% | $919.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 44.32M | — | $670.60M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | BlackRock ✦ (pasivo) | 39.72M | -1.5% | $601.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | The Vanguard Group ✦ (pasivo) | 38.80M | -1.3% | $587.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | The Vanguard Group ✦ (pasivo) | 38.80M | -1.3% | $587.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | The Vanguard Group ✦ (pasivo) | 38.80M | -1.3% | $587.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | The Vanguard Group ✦ (pasivo) | 38.80M | -1.3% | $587.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | The Vanguard Group ✦ (pasivo) | 38.80M | -1.3% | $587.12M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Viking Global Investors ✦ | 23.59M | -31.1% | $356.99M | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 40 | State Street Global Advisors ✦ (pasivo) | 18.70M | -5.4% | $282.93M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 41 | Geode Capital Management ✦ (pasivo) | 8.20M | +5.8% | $124.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Geode Capital Management ✦ (pasivo) | 8.20M | +5.8% | $124.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Adage Capital Partners ✦ | 7.23M | +247.3% | $109.43M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 44 | Marshall Wace ✦ | 3.98M | +316.5% | $60.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 45 | Marshall Wace ✦ | 3.98M | +316.5% | $60.19M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 46 | T. Rowe Price ✦ | 2.92M | +98.5% | $44.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 2.92M | +98.5% | $44.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Point72 Asset Management ✦ | 2.61M | -11.6% | $39.46M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 49 | Millennium Management ✦ | 2.59M | +167.9% | $39.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | JPMorgan Chase ✦ | 2.46M | — | $37.20M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Goldman Sachs Group ✦ | 2.36M | — | $35.72M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Goldman Sachs Group ✦ | 2.36M | — | $35.72M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Goldman Sachs Group ✦ | 2.36M | — | $35.72M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Goldman Sachs Group ✦ | 2.36M | — | $35.72M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Greenlight Capital (DME Capital) ✦ | 2.28M | -50.0% | $34.43M | 1.4% | ▼ Trim | 6 | SEC ↗ |
| 63 | Greenlight Capital (DME Capital) ✦ | 2.28M | -50.0% | $34.43M | 1.4% | ▼ Trim | 6 | SEC ↗ |
| 64 | Greenlight Capital (DME Capital) ✦ | 2.28M | -50.0% | $34.43M | 1.4% | ▼ Trim | 6 | SEC ↗ |
| 65 | Citadel Advisors ✦ | 968.20K | +96.7% | $14.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 66 | D. E. Shaw & Co. ✦ | 548.06K | +554.9% | $8.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 67 | D. E. Shaw & Co. ✦ | 548.06K | +554.9% | $8.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 68 | Gotham Asset Management ✦ | 330.48K | +744.1% | $5.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 69 | AQR Capital Management ✦ | 70.37K | Nuevo | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 70 | AQR Capital Management ✦ | 70.37K | Nuevo | $1.06M | 0.0% | New | 1 | SEC ↗ |
| 71 | AQR Capital Management ✦ | 70.37K | Nuevo | $1.06M | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| AQR Capital Management | $1.06M | 0.0% |
| AQR Capital Management | $1.06M | 0.0% |
| AQR Capital Management | $1.06M | 0.0% |
Posición cerrada
| Norges Bank | $6.95M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 436 tenedores, 528.48M acciones, $14.35B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Aug 21
Sukhatme Mayukh
Officer, Director · 144.76K acc. · $5.28M
Aug 20
Sukhatme Mayukh
Officer, Director · 17.52K acc. · $653,459
Aug 19
Sukhatme Mayukh
Officer, Director · 172.90K acc. · $6.43M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
Aug 13
SC 13G/A — MORGAN STANLEY
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API